603987 Shanghai Kindly Enterprise Development Group
- 6.67
- +0.17+2.62%
Shanghai Kindly Enterprise Development Group News
Shanghai Kindly Enterprise Development Group (603987.SH) annual equity distribution for year 2023: a dividend of 0.16 yuan per share on June 13 for shareholders on record.
Shanghai Kindly Enterprise Development Group (603987.SH) has released the announcement of the distribution of equity for the year 2023. The distribution of profits this time is based on the total share capital before the implementation of the stock-based incentive plan, deducting the inventory shares that have not been implemented. A cash dividend of 0.16 yuan per share (tax included) will be distributed to all shareholders. The ex-dividend (interest) date is June 14, 2024, and the record date is June 13, 2024.
Kendley (603987.SH) announced first-quarter results, net profit of 605.359 million yuan, down 28.88% year on year
Kendley (603987.SH) disclosed its report for the first quarter of 2024. The company achieved operating income of 5 during the reporting period...
Kendley (603987.SH) announced first-quarter results. Net profit attributable to mother was 231 million yuan, a year-on-year decrease of 25.93%
Kendley (603987.SH) released its 2023 annual report, and the group achieved operating income of 24 during the period...
Earnings Are Growing at Shanghai Kindly Enterprise Development GroupLTD (SHSE:603987) but Shareholders Still Don't Like Its Prospects
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But the long term shareholders of Shanghai Kindly Enterprise Development Group Co.,L
Kendra (603987.SH): Wholly-owned subsidiary re-certified as a high-tech enterprise
Gelonghui, March 22丨Kendley (603987.SH) announced that its wholly-owned subsidiary Guangdong Kendley Medical Devices Group Co., Ltd. recently received a “High-tech Enterprise Certificate” jointly issued by the Guangdong Provincial Department of Science and Technology, the Guangdong Provincial Department of Finance, and the Guangdong Provincial Taxation Bureau of the State Administration of Taxation. Guangdong Medical Devices Group obtained the high-tech enterprise certificate in 2020. This high-tech enterprise certification is a re-certification carried out after the original certificate expires.
Shanghai Kindly Enterprise Development Group Co.,LTD.'s (SHSE:603987) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Shanghai Kindly Enterprise Development GroupLTD (SHSE:603987) has had a rough three months with its share price down 19%. But if you pay close attention, you might find that its key financial indica
Kendry Medical (01501.HK) plans to change its name to “Yingtai Medical”
Gelonghui, January 16, 丨 KDL Medical (01501.HK) issued an announcement. Starting at 9:00 a.m. on January 19, 2024, the Chinese stock abbreviation used in H shares trading on the Stock Exchange will be changed from “KDL Medical” to “Yingtai Medical”, and the English language will be changed from “KDL MEDICAL” to “INT MEDICAL”. The company's stock code on the Stock Exchange will remain unchanged as “01501”.
Kendra (603987.SH): Wholly-owned subsidiary obtains high-tech enterprise certificate
Gelonghui, January 11丨Kendley (603987.SH) announced that Zhejiang Kendley Medical Devices Co., Ltd. (“Zhejiang Kangdelai”), a wholly-owned subsidiary of the company, recently received the “High-tech Enterprise Certificate” jointly issued by the Zhejiang Provincial Department of Science and Technology, the Zhejiang Provincial Department of Finance, and the Zhejiang Taxation Bureau of the State Administration of Taxation. Certificate number: GR202333001240, date of issue: December 8, 2023, validity period: 3 years.
Kindley Medical (01501.HK) proposes to grant 5 million restricted shares under the 2023 Equity Incentive Plan through the issuance of new domestic shares
GLONGHUI November 24 | Kindly Medical (01501.HK) announced that the board of directors proposed to grant 5 million restricted shares under the 2023 equity incentive plan through the issuance of new domestic shares. Such grants can only be implemented after shareholders have approved the adoption of the 2023 equity incentive plan at the rescheduled special general meeting of shareholders. It is proposed to recognize the contribution of the incentive target and grant incentives according to the purpose and goal of granting restricted shares in accordance with the 2023 equity incentive plan, so as to retain the incentive target as a service for the Group's continuous operation and development. The Board of Directors and the Remuneration Committee believe that the purpose of the proposed award is to reward incentive recipients for the past
Kendley (603987.SH) released the first three quarter results, net profit of 187 million yuan, down 27.05% year on year
Kendley (603987.SH) disclosed its report for the third quarter of 2023. The company achieved revenue of 1 during the reporting period...
Kindley Medical Devices (01501) will apply for approval to distribute 3 million new domestic shares to Liang Dongke and the Stock Incentive Platform in due course
Kindley Medical Devices (01501) announced that on October 17, 2023, the company announced that the company is based on a stock incentive plan...
Shanghai Kindly Enterprise Development GroupLTD (SHSE:603987) Sheds 7.7% This Week, as Yearly Returns Fall More in Line With Earnings Growth
It hasn't been the best quarter for Shanghai Kindly Enterprise Development Group Co.,LTD. (SHSE:603987) shareholders, since the share price has fallen 17% in that time. But that doesn't change the
Kindley (603987.SH): It is one of the few domestic manufacturers with a complete medical puncture device industry chain
Glonghui, Oct. 16 | On the investor interactive platform, Condeley (603987.SH) said that our company's main products are medical puncture devices, and it is one of the few domestic manufacturers with a complete medical puncture device industry chain. Currently, the company has ten categories of products, namely: puncture care, infusion catheters, medical aesthetics, medicine packaging materials, puncture intervention, specimen collection, insulin administration, indwelling infusion, active devices, and veterinary medicine.
Kindley Medical Devices (01501) proposes to adopt the 2023 equity incentive plan
Kindley Medical Devices (01501) issued an announcement. The board of directors recommended adopting the 2023 equity incentive plan. The plan covers...
Individual Investors Are Shanghai Kindly Enterprise Development Group Co.,LTD.'s (SHSE:603987) Biggest Owners and Were Hit After Market Cap Dropped CN¥394m
Key Insights Significant control over Shanghai Kindly Enterprise Development GroupLTD by individual investors implies that the general public has more power to influence management and governance-rela
Condeley (603987.SH): Net profit of 134 million yuan in the first half of the year fell 23.57% year-on-year
Glonghui, August 25: Condeley (603987.SH) announced its semi-annual report. Operating income was 1.28 billion yuan, down 21.93% year on year, net profit was 134 million yuan, down 23.57% year on year, after deducting non-net profit of 129 million yuan, down 24.49% year on year, and basic earnings per share were 0.30 yuan.
[Brokerage Focus] CMB International maintains Condeley Medical Devices (01501) purchase rating, indicating that collection has limited impact on its profitability
According to the CMB International Research and Development Report, Kindley Medical Devices (01501) announced its 1H23 results. In the first half of the year, due to a rapid recovery in demand for interventional surgery, the company's revenue increased 50.9% year-on-year to 340 million yuan. The gross margin for the first half of the year increased 3.9 percentage points to 59% year-on-year, mainly due to the improvement in gross profit of interventional medical devices and the increase in their share of revenue. In the first half of the year, gross margin of interventional medical devices increased by about 2 percentage points to 65%, accounting for 89% of revenue, compared to 85% for the same period last year. Revenue growth and gross profit increased the company's net profit by 583% year-on-year to 80.5 million yuan. This line refers to
Kindley Medical Devices announces interim results, profit attributable to shareholders of 805.02 million yuan, up 58.34% year-on-year
Kindley Medical (01501) announced its results for the six months ended June 30, 2023. Group revenue was RMB 340 million (same unit), up 50.86% year on year; profit attributable to shareholders was RMB 805.02 million, up 58.34% year on year; and basic profit of 0.48 yuan per share. The announcement stated that the increase in revenue was mainly due to an increase in market demand for the Group's products and an increase in the number of new Group customers.
Kendley Medical Devices (01501.HK) plans to hold a board meeting on August 18 to approve interim results
On August 8, 2023 (Friday), GLONGHUI (01501.HK) announced that the company will hold a board meeting on August 18, 2023 (Friday) to approve (among others) the unaudited interim results of the company and its subsidiaries for publication for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
Kendrei Medical's Fa Yingxi expects net profit to increase by about 50% year-on-year in the first half of the year
Kendley Medical Devices (01501) announced that the net profit of the Group's 2023 interim results is expected to increase by about 50% over the six months ending June 30, 2022 (2022 interim results: RMB 50,125 million). According to the announcement, the expected sharp increase in net profit in the first half of 2023 is mainly due to the increase in market demand for the Group's products and the increase in the number of new customers added by the Group.
Analysis
Price Target
No Data
